Randsøe T, Kvist T M, Hyldegaard O
Laboratory of Hyperbaric Medicine, Department of Anesthesia, Center of Head and Orthopedics, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen Ø, DK-Denmark.
J Appl Physiol (1985). 2008 Nov;105(5):1492-7. doi: 10.1152/japplphysiol.90840.2008. Epub 2008 Aug 28.
At altitude, bubbles are known to form and grow in blood and tissues causing altitude decompression sickness. Previous reports indicate that treatment of decompression sickness by means of oxygen breathing at altitude may cause unwanted bubble growth. In this report we visually followed the in vivo changes of micro air bubbles injected into adipose tissue of anesthetized rats at 101.3 kPa (sea level) after which they were decompressed from 101.3 kPa to and held at 25 kPa (10,350 m), during breathing of oxygen or a heliox(34:66) mixture (34% helium and 66% oxygen). Furthermore, bubbles were studied during oxygen breathing preceded by a 3-h period of preoxygenation to eliminate tissue nitrogen before decompression. During oxygen breathing, bubbles grew from 11 to 198 min (mean: 121 min, +/-SD 53.4) after which they remained stable or began to shrink slowly. During heliox breathing bubbles grew from 30 to 130 min (mean: 67 min, +/-SD 31.0) from which point they stabilized or shrank slowly. No bubbles disappeared during either oxygen or heliox breathing. Preoxygenation followed by continuous oxygen breathing at altitude caused most bubbles to grow from 19 to 179 min (mean: 51 min, +/-SD 47.7) after which they started shrinking or remained stable throughout the observation period. Bubble growth time was significantly longer during oxygen breathing compared with heliox breathing and preoxygenated animals. Significantly more bubbles disappeared in preoxygenated animals compared with oxygen and heliox breathing. Preoxygenation enhanced bubble disappearance compared with oxygen and heliox breathing but did not prevent bubble growth. The results indicate that oxygen breathing at 25 kPa promotes air bubble growth in adipose tissue regardless of the tissue nitrogen pressure.
在高海拔地区,已知气泡会在血液和组织中形成并生长,从而导致高空减压病。先前的报告表明,在高海拔地区通过吸氧治疗减压病可能会导致不必要的气泡生长。在本报告中,我们在101.3 kPa(海平面)下,对注入麻醉大鼠脂肪组织中的微气泡进行了体内观察,随后将其从101.3 kPa减压至25 kPa(10350米)并保持在该压力下,期间大鼠呼吸氧气或氦氧混合气(34:66)(34%氦气和66%氧气)。此外,在减压前进行3小时预充氧以消除组织中的氮气后,研究了吸氧过程中的气泡情况。在吸氧过程中,气泡在11至198分钟内生长(平均:121分钟,±标准差53.4),之后保持稳定或开始缓慢收缩。在氦氧混合气呼吸过程中,气泡在30至130分钟内生长(平均:67分钟,±标准差31.0),此后稳定或缓慢收缩。在吸氧或氦氧混合气呼吸过程中,均无气泡消失。在高海拔地区进行预充氧后持续吸氧,导致大多数气泡在19至179分钟内生长(平均:51分钟,±标准差47.7),之后在整个观察期内开始收缩或保持稳定。与氦氧混合气呼吸和预充氧的动物相比,吸氧过程中气泡生长时间显著更长。与吸氧和氦氧混合气呼吸相比,预充氧的动物中气泡消失的数量显著更多。与吸氧和氦氧混合气呼吸相比,预充氧增强了气泡的消失,但并未阻止气泡生长。结果表明,在25 kPa下吸氧会促进脂肪组织中气泡的生长,而与组织中的氮气压力无关。